Imidazole → tert-butyl (2S)-2-fluoro-3-iodopropylcarbamate

HRID 1797443ノート

反応式

HRID 1797443 の反応式
N1C=CN=C1.[I:6]I.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.[F:27][C@H:28]([CH2:38]O)[CH2:29][NH:30][C:31](=[O:37])[O:32][C:33]([CH3:36])([CH3:35])[CH3:34]>C(Cl)Cl>[F:27][C@H:28]([CH2:38][I:6])[CH2:29][NH:30][C:31](=[O:37])[O:32][C:33]([CH3:36])([CH3:35])[CH3:34]

参加物

6

実験手順

Imidazole (19.8 g, 0.29 mol) was dissolved in methylene chloride (900 mL) at room temperature. Iodine (73.9 g, 0.29 mol) was added and the reaction mixture was stirred for 10 min at room temperature and then cooled to 0° C. Triphenylphosphine (76.3 g, 0.29 mol) was added portionwise over 10 min such that the internal temperature remained below 10° C. A solution of tert-butyl (2S)-2-fluoro-3-hydroxypropylcarbamate (45.0 g, 0.23 mol) in methylene chloride (300 mL) was added dropwise. The reaction mixture was allowed to warm to room temperature and stirring was continued for 12 h. The reaction mixture was filtered through a pad of Celite® and washed with additional methylene chloride. The filtrate was concentrated under reduced pressure and purified by silica gel column chromatography eluting with methylene chloride. This procedure afforded tert-butyl (2S)-2-fluoro-3-iodopropylcarbamate as a colorless oil (42.5 g, 62%). 1H NMR (300 MHz, CDCl3) δ 4.80–5.10 (br s, 1H), 4.58–4.72 (m, 0.5H), 4.42–4.56 (m, 0.5 H), 3.48–3.70 (m, 1H), 3.20–3.46 (m, 3H), 1.48 (s, 9H).

後処理

  1. temperaturecooled to 0° C
  2. customremained below 10° C
  3. temperatureto warm to room temperature
  4. stirringstirring
  5. waitwas continued for 12 h
  6. filtrationThe reaction mixture was filtered through a pad of Celite®
  7. washwashed with additional methylene chloride
  8. concentrationThe filtrate was concentrated under reduced pressure
  9. custompurified by silica gel column chromatography
  10. washeluting with methylene chloride

出典と根拠

ORDレコード
ord-5b6cda1d5bd048a290beb24ea4898c72
出典データセット
uspto-grants-2006_04
特許番号
US07034176B2

反応ノート

読み込み中…